Growth Metrics

Pacific Biosciences Of California (PACB) Notes Payables (2017 - 2023)

Pacific Biosciences Of California (PACB) has 6 years of Notes Payables data on record, last reported at $2.3 million in Q4 2022.

  • For Q4 2022, Notes Payables changed N/A year-over-year to $2.3 million; the TTM value through Dec 2022 reached $2.3 million, changed N/A, while the annual FY2022 figure was $2.3 million, N/A changed from the prior year.
  • Notes Payables reached $2.3 million in Q4 2022 per PACB's latest filing, down from $15.9 million in the prior quarter.
  • Across five years, Notes Payables topped out at $15.9 million in Q4 2019 and bottomed at $2.3 million in Q4 2022.